Ochsner LSU Health Monroe

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Hospital inpatient/24-hour hospital inpatient

Facility Type

Separate inpatient psychiatric unit of a general hospital

Pharmacotherapies

Chlorpromazine Droperidol Fluphenazine Haloperidol Thiothixene Aripiprazole Brexpiprazole Cariprazine Clozapine Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Activity therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale

Emergency Mental Health Services

Psychiatric emergency onsite services Psychiatric emergency walk-in services

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

Medicare Medicaid Federal military insurance (e.g., TRICARE) Other State funds Private health insurance Cash or self-payment State-financed health insurance plan other than Medicaid U.S. Department of VA funds

Special Programs/Groups Offered

Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Testing

HIV testing STD testing TB screening Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV) Laboratory testing

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Young Adults Adults

Language Services

Sign language services for the deaf and hard of hearing

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Court-ordered outpatient treatment Diet and exercise counseling Legal advocacy Case management service Suicide prevention services